// App-Quantinova.ai

P073 : The Effect Of Cladribine Tablets In Patients With Relapsing-remitting Multiple Sclerosis Who Had Evidence Of Disease Activity In CLARITY

Researchers

Presenter

  • B. M. Greenberg

Principal Investigators

  • K. Rammohan

  • J. Aldridge

  • L. A. Lebson

  • F. Dangond

  • G. Giovannoni

Medical Centers

  • UTSouthwestern Medical Center, Dallas, TX

  • University of Miami, Miami, FL

  • EMD Serono, Inc, Billerica, MA

  • EMD Serono, Rockland, MD

  • Gastroenterology, Blizard Institute of Cell and Molecular Science, London, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • EMD Serono Inc.

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Multiple Sclerosis

Biomarkers

  • N/A

Drug/Treatment

  • Cladribine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved